(1)
Abbarin, N.; Papp, K.; Vender, R.; Langley, R. .; Ho, V.; Park-Wyllie, L.; Miller, M.; You, Y.; Yang, Y.-W. PASI Improvement in the First 12 Weeks from the Phase 3 VOYAGE 1, VOYAGE 2, ORION and ECLIPSE Guselkumab Clinical Trials. J of Skin 2023, 7, s237.